These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19589785)

  • 1. HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphorylation.
    García-Castillo J; Pedersen K; Angelini PD; Bech-Serra JJ; Colomé N; Cunningham MP; Parra-Palau JL; Canals F; Baselga J; Arribas J
    J Biol Chem; 2009 Sep; 284(37):25302-13. PubMed ID: 19589785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers.
    Parra-Palau JL; Pedersen K; Peg V; Scaltriti M; Angelini PD; Escorihuela M; Mancilla S; Sánchez Pla A; Ramón Y Cajal S; Baselga J; Arribas J
    Cancer Res; 2010 Nov; 70(21):8537-46. PubMed ID: 20978202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.
    Pedersen K; Angelini PD; Laos S; Bach-Faig A; Cunningham MP; Ferrer-Ramón C; Luque-García A; García-Castillo J; Parra-Palau JL; Scaltriti M; Ramón y Cajal S; Baselga J; Arribas J
    Mol Cell Biol; 2009 Jun; 29(12):3319-31. PubMed ID: 19364815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p95HER2 and breast cancer.
    Arribas J; Baselga J; Pedersen K; Parra-Palau JL
    Cancer Res; 2011 Mar; 71(5):1515-9. PubMed ID: 21343397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphorylated cortactin in cancer cells plays an inhibitory role in cell motility.
    Jia L; Uekita T; Sakai R
    Mol Cancer Res; 2008 Apr; 6(4):654-62. PubMed ID: 18403644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration.
    Bourguignon LY; Zhu H; Shao L; Chen YW
    J Biol Chem; 2001 Mar; 276(10):7327-36. PubMed ID: 11084024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells.
    Mezi S; Todi L; Orsi E; Angeloni A; Mancini P
    Int J Oncol; 2012 Dec; 41(6):2128-38. PubMed ID: 23023326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mena
    Weidmann MD; Surve CR; Eddy RJ; Chen X; Gertler FB; Sharma VP; Condeelis JS
    Sci Rep; 2016 Nov; 6():36142. PubMed ID: 27824079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.
    Anido J; Scaltriti M; Bech Serra JJ; Santiago Josefat B; Todo FR; Baselga J; Arribas J
    EMBO J; 2006 Jul; 25(13):3234-44. PubMed ID: 16794579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
    Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.
    Damiano L; Le Dévédec SE; Di Stefano P; Repetto D; Lalai R; Truong H; Xiong JL; Danen EH; Yan K; Verbeek FJ; De Luca E; Attanasio F; Buccione R; Turco E; van de Water B; Defilippi P
    Oncogene; 2012 Feb; 31(5):624-33. PubMed ID: 21725361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of the actin binding domain of human cortactin affects cell migration.
    van Rossum AG; de Graaf JH; Schuuring-Scholtes E; Kluin PM; Fan YX; Zhan X; Moolenaar WH; Schuuring E
    J Biol Chem; 2003 Nov; 278(46):45672-9. PubMed ID: 12952985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin.
    Eiseler T; Hausser A; De Kimpe L; Van Lint J; Pfizenmaier K
    J Biol Chem; 2010 Jun; 285(24):18672-83. PubMed ID: 20363754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori.
    Tegtmeyer N; Wittelsberger R; Hartig R; Wessler S; Martinez-Quiles N; Backert S
    Cell Host Microbe; 2011 Jun; 9(6):520-31. PubMed ID: 21669400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton.
    Head JA; Jiang D; Li M; Zorn LJ; Schaefer EM; Parsons JT; Weed SA
    Mol Biol Cell; 2003 Aug; 14(8):3216-29. PubMed ID: 12925758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
    Sengupta S; Schiff R; Katzenellenbogen BS
    Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of cortactin in tumor pathogenesis.
    Buday L; Downward J
    Biochim Biophys Acta; 2007 Jun; 1775(2):263-73. PubMed ID: 17292556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.
    Hashimoto S; Hirose M; Hashimoto A; Morishige M; Yamada A; Hosaka H; Akagi K; Ogawa E; Oneyama C; Agatsuma T; Okada M; Kobayashi H; Wada H; Nakano H; Ikegami T; Nakagawa A; Sabe H
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7036-41. PubMed ID: 16636290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.